Invacare Stock Price, Forecast & Analysis (NYSE:IVC)

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Invacare declared a quarterly dividend on Thursday, August 29th. Stockholders of record on Friday, October 11th will be given a dividend of $0.125 per share on Friday, October 25th. This represents a $0.50 annualized dividend and a dividend yield of 5.48%. The ex-dividend date of this dividend is Thursday, October 10th. This is an increase from Invacare's previous quarterly dividend of $0.01. View Invacare's Dividend History.

Invacare Co. (NYSE:IVC) posted its earnings results on Wednesday, November, 6th. The health services provider reported ($0.15) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.20) by $0.05. The health services provider earned $235.80 million during the quarter, compared to the consensus estimate of $244.81 million. Invacare had a negative return on equity of 9.30% and a negative net margin of 3.82%. Invacare's revenue was down 3.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.40) EPS. View Invacare's Earnings History.

Invacare is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Invacare.

1 Wall Street analysts have issued 12 month price objectives for Invacare's shares. Their forecasts range from $15.00 to $15.00. On average, they anticipate Invacare's stock price to reach $15.00 in the next twelve months. This suggests a possible upside of 64.5% from the stock's current price. View Analyst Price Targets for Invacare.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Invacare.

Press coverage about IVC stock has trended very negative this week, InfoTrie reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Invacare earned a daily sentiment score of -3.9 on InfoTrie's scale. They also assigned news stories about the health services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Invacare.

Some companies that are related to Invacare include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include ImmunoGen (IMGN), Opko Health (OPK), ResMed (RMD), Catalyst Pharmaceuticals (CPRX), Immunomedics (IMMU), Lexicon Pharmaceuticals (LXRX), TherapeuticsMD (TXMD), Chesapeake Energy (CHK), NovaBay Pharmaceuticals (NBY) and Abeona Therapeutics (ABEO).

Invacare's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Stephens Inc. AR (0.87%), Essex Investment Management Co. LLC (0.63%), Rhumbline Advisers (0.33%), Monarch Partners Asset Management LLC (0.25%), Adirondack Research & Management Inc. (0.20%) and Mackay Shields LLC (0.18%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, C Martin Harris, Clifford D Nastas, Dean J Childers, Kathleen P Leneghan and Matthew E Monaghan. View Institutional Ownership Trends for Invacare.

IVC stock was sold by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Adirondack Research & Management Inc. and Nisa Investment Advisors LLC. View Insider Buying and Selling for Invacare.

IVC stock was acquired by a variety of institutional investors in the last quarter, including Stephens Inc. AR, Mackay Shields LLC, Dupont Capital Management Corp, BBVA USA Bancshares Inc., State of Alaska Department of Revenue, Eagle Asset Management Inc., Tower Research Capital LLC TRC and Rhumbline Advisers. Company insiders that have bought Invacare stock in the last two years include Clifford D Nastas, Kathleen P Leneghan and Matthew E Monaghan. View Insider Buying and Selling for Invacare.

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IVC stock can currently be purchased for approximately $9.12.

Invacare has a market capitalization of $306.95 million and generates $972.35 million in revenue each year. The health services provider earns $-43,920,000.00 in net income (profit) each year or ($1.32) on an earnings per share basis. Invacare employs 4,200 workers across the globe.View Additional Information About Invacare.

The official website for Invacare is http://www.invacare.com/.

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44035. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected]